Literature DB >> 10598656

Bone marrow transplantation for sickle cell disease: where do we go from here?

M C Walters1.   

Abstract

Bone marrow transplantation has curative potential for patients who have sickle cell disease. However, concerns about short-term and long-term toxicity, lack of suitable stem cell donors, and limited access to this treatment currently make it an infrequently utilized treatment for sickle cell disease. The current results of bone marrow transplantation for sickle cell disease and barriers to wider application are reviewed. Strategies that might lead to broader availability and reduced toxicity of bone marrow transplantation are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10598656     DOI: 10.1097/00043426-199911000-00005

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Effectiveness of antenatal screening for sickle cell trait: the impact on women's self-report of sickle cell trait status.

Authors:  J M Knight-Madden; M Reid; N Younger; D Francis; S McFarlane; R Wilks
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

2.  Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait.

Authors:  Marsha J Treadwell; Lakenya McClough; Elliott Vichinsky
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

3.  Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

Authors:  R C Young; R E Rachal; M Del Pilar Aguinaga; B L Nelson; B C Kim; W P Winter; O Castro
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.